David Phizackerley

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Venous Thromboembolism

Respiratory Syndrome Coronavirus

Induced Pluripotent Stem Cells

Top Venues

Drug and therapeutics bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

David Phizackerley
Supporting the treatment of obesity. Drug and therapeutics bulletin (2024)
David Phizackerley
Protecting consumers: a rich legacy. Drug and therapeutics bulletin 62 (3) (2024)
David Phizackerley
Protecting consumers: a rich legacy. Drug and therapeutics bulletin 62 (3) (2024)
David Phizackerley
Protecting consumers: a rich legacy. Drug and therapeutics bulletin 62 (3) (2024)
David Phizackerley
Protecting consumers: a rich legacy. Drug and therapeutics bulletin (2024)
David Phizackerley
Taxing ill health. Drug and therapeutics bulletin (2023)
James A Cave, David Phizackerley
What does DTB stand for? Drug and therapeutics bulletin 61 (5) (2023)
David Phizackerley
Moving with the times. Drug and therapeutics bulletin 61 (11) (2023)
David Phizackerley
Swapping patients to edoxaban but at what cost? Drug and therapeutics bulletin (2022)
David Phizackerley, James A Cave
From info-desert to info-demic: the role of independent drug bulletins. Drug and therapeutics bulletin 60 (5) (2022)
David Phizackerley
Therapeutic value of human faeces. Drug and therapeutics bulletin (2022)
David Phizackerley, Joanna Girling, James A Cave
Desogestrel POM to P: for the few not the many? Drug and therapeutics bulletin 59 (10) (2021)
James A Cave, David Phizackerley
Molnupiravir: evidence by press release. Drug and therapeutics bulletin (2021)
David Phizackerley
Aducanumab for Alzheimer's disease - too many unanswered questions. Drug and therapeutics bulletin 59 (9) (2021)
David Phizackerley
Covid-19 vaccination-we need more than the 'mum test'. Drug and therapeutics bulletin 59 (1) (2020)
David Phizackerley
Registering our interest. Drug and therapeutics bulletin 58 (2) (2020)
David Phizackerley, James A Cave
What price Priadel? Drug and therapeutics bulletin 58 (12) (2020)
James A Cave, David Phizackerley
Virtual revolution? Drug and therapeutics bulletin 58 (8) (2020)
David Phizackerley
Deprescribing in the time of covid-19. Drug and therapeutics bulletin 58 (6) (2020)
David Phizackerley
If the drugs don't work. Drug and therapeutics bulletin 57 (6) (2020)
David Phizackerley
Making medicines safer? Drug and therapeutics bulletin 58 (10) (2020)
David Phizackerley
Social prescribing: right idea, wrong name? Drug and therapeutics bulletin 57 (9) (2019)